Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

August 2016 - FRMC

Department

News Connection
08/15/2016
The state of Arizona is rejoining the Children’s Health Insurance Program (CHIP) after shutting it down in 2009 in response to the recession.
The state of Arizona is rejoining the Children’s Health Insurance Program (CHIP) after shutting it down in 2009 in response to the recession.
The state of Arizona is...
08/15/2016
First Report Managed Care
News Connection
08/15/2016
Biosimilar tumor necrosis factor-alpha (TNF-α) inhibitors have very similar safety and effectiveness as their reference biologics, according to a recent systematic review and meta-analysis..
Biosimilar tumor necrosis factor-alpha (TNF-α) inhibitors have very similar safety and effectiveness as their reference biologics, according to a recent systematic review and meta-analysis..
Biosimilar tumor necrosis...
08/15/2016
First Report Managed Care
News Connection
08/15/2016
An enhanced risk prediction model that considers not only chronic comorbidities but also health factors not typically accounted for in other models improved risk prediction for emergency department (ED) use and hospitalization among a group...
An enhanced risk prediction model that considers not only chronic comorbidities but also health factors not typically accounted for in other models improved risk prediction for emergency department (ED) use and hospitalization among a group...
An enhanced risk prediction...
08/15/2016
First Report Managed Care
News Connection
08/15/2016
A recent report from the CMS shows that efforts to prevent fraudulent and improper payments in Medicare and Medicaid saved billions of dollars.
A recent report from the CMS shows that efforts to prevent fraudulent and improper payments in Medicare and Medicaid saved billions of dollars.
A recent report from the...
08/15/2016
First Report Managed Care
News Connection
08/15/2016
Recent research in The BMJ posits that when pharmaceutical companies acquire promising drug compounds through late-stage bidding wars that escalate “development costs,” and then turn around and charge exorbitant prices that primarily benefit...
Recent research in The BMJ posits that when pharmaceutical companies acquire promising drug compounds through late-stage bidding wars that escalate “development costs,” and then turn around and charge exorbitant prices that primarily benefit...
Recent research in The BMJ...
08/15/2016
First Report Managed Care
News Connection
08/15/2016
Results of a national survey of US physicians conducted to evaluate self-reported rationing behavior showed that more than half of respondents said they participated in behavior consistent with rationing.
Results of a national survey of US physicians conducted to evaluate self-reported rationing behavior showed that more than half of respondents said they participated in behavior consistent with rationing.
Results of a national survey of...
08/15/2016
First Report Managed Care
Formulary Frontlines®
08/15/2016
Although melanoma, an aggressive malignant cancer of melanocytes, represents less than 5% of skin cancers, it accounts for approximately 75% of skin cancer-related deaths, according to the American Cancer Society. 
Although melanoma, an aggressive malignant cancer of melanocytes, represents less than 5% of skin cancers, it accounts for approximately 75% of skin cancer-related deaths, according to the American Cancer Society. 
Although melanoma, an aggressive...
08/15/2016
First Report Managed Care

News

News
08/15/2016
Safety and effectiveness analyses comparing the antiplatelets Effient and Plavix after percutaneous coronary intervention demonstrated different findings.
Safety and effectiveness analyses comparing the antiplatelets Effient and Plavix after percutaneous coronary intervention demonstrated different findings.
Safety and effectiveness...
08/15/2016
First Report Managed Care
Department
08/15/2016
Research presented at the EULAR 2016 Congress showed that rheumatologists in the UK diverge from the National Institute for Health and Care Excellence’s (NICE) TNF inhibitor prescribing guidance when treating patients with rheumatoid...
Research presented at the EULAR 2016 Congress showed that rheumatologists in the UK diverge from the National Institute for Health and Care Excellence’s (NICE) TNF inhibitor prescribing guidance when treating patients with rheumatoid...
Research presented at the EULAR...
08/15/2016
First Report Managed Care
Department
08/15/2016
A reduced formulation of Humira (adalimumab; Abbvie Inc) for the treatment of rheumatoid arthritis produced less adverse events, specifically injection site pain, when compared with the current formulation, according to data presented at the...
A reduced formulation of Humira (adalimumab; Abbvie Inc) for the treatment of rheumatoid arthritis produced less adverse events, specifically injection site pain, when compared with the current formulation, according to data presented at the...
A reduced formulation of Humira...
08/15/2016
First Report Managed Care

Advertisement

Advertisement

Advertisement